PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Preventive ablation of ventricular tachycardia avoids shocks and hospitalisation

PREVENTIVE VT trial presented in a late-breaking science session today at EHRA 2024

2024-04-08
(Press-News.org) Berlin, Germany – 8 April 2024:  The first randomised trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients at high risk of ventricular arrhythmias (VAs)  reduces the risk of appropriate implantable cardioverter-defibrillator (ICD) therapy and unplanned hospitalisation in patients with no previously recorded VAs. The late-breaking science is presented at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).1

 

Principal investigator Dr. David Zizek of the University Medical Centre Ljubljana, Slovenia said: “In everyday clinical practice, ventricular tachycardia (VT) ablation is still often regarded as a last resort in the management of patients with ischaemic cardiomyopathy. We hypothesised that ablation early in the course of the disease, when patients have a lower burden of comorbidities, might be associated with fewer periprocedural complications and improved clinical outcomes compared to withholding the procedure until several ICD shocks have occurred. Our study shows that a primary prevention ablation strategy can be a safe and effective treatment option to prevent ICD interventions and arrhythmia-related hospitalisations.”

 

ICD therapy is recommended for primary prevention of sudden cardiac death in ischaemic cardiomyopathy patients with reduced ejection fraction despite optimal medical treatment.2 Approximately one in three ischaemic cardiomyopathy patients with previous myocardial infarction have infarct-related coronary CTO.3 Infarct-related CTO is a strong and independent predictor of VAs in ischaemic patients with a primary prevention ICD.3 Appropriate ICD shocks are live-saving, but are linked with reduced quality of life, physiological distress, pain, heart failure hospitalisation, and cardiovascular death. However, the optimal time to perform VT ablation is uncertain.

 

The PREVENTIVE VT trial investigated the impact of preventive VT ablation on ICD interventions in patients with ischaemic cardiomyopathy and infarct-related coronary CTO. The trial was conducted at four centres in Slovenia between September 2017 and January 2024. It enrolled patients with ischaemic cardiomyopathy, reduced ejection fraction (≤40%), angiographically proven coronary CTO associated with previous myocardial infarction, and no previously documented sustained VAs. In addition, patients were not eligible for revascularisation, were on optimal medical therapy, and had an indication for primary prevention ICD implantation.

 

Participants were randomly assigned 1:1 to preventive substrate ablation before ICD implantation (preventive ablation group) or ICD implantation only (standard therapy group). The purpose of ablation was to abolish abnormal ventricular electrograms within the scar and its border and achieve non-inducibility of monomorphic VT after a uniform stimulation protocol. High-density voltage mapping with a 3D electroanatomical mapping system was used to delineate the infarct-related CTO and the border zone, and scar homogenisation was performed. Primary prevention ICD settings for arrhythmia detection and therapy were recommended for both groups.

 

The primary outcome was a composite of appropriate ICD therapy or unplanned hospital admission for symptomatic VAs. Secondary outcomes included the incidence of appropriate ICD therapies, unplanned VA-related hospitalisation, cardiac hospitalisation (due to VA or worsening heart failure), electrical storm, and cardiovascular mortality.

 

A total of 60 patients were enrolled (30 in each group). The average age was 67.5 ± 8.1 years and 91.7% were male. In the preventive ablation group, total elimination of abnormal electrograms was achieved in 26 (86.7%) patients and VT was not inducible in 27 (90%) patients. There were 2 (6.6%) major complications associated with the ablation procedure.

 

During a mean follow-up of 44.73 months, the primary endpoint occurred in 5 (16.7%) patients undergoing ablation and 13 (43.3%) patients receiving an ICD only (multivariate hazard ratio [HR] 0.32, 95% confidence interval [CI] 0.11-0.91; p=0.032). Univariate analyses showed that patients in the ablation group had fewer appropriate ICD therapies (17% vs. 40%; HR 0.37, 95% CI 0.13-1.05, p=0.051), unplanned VA-related hospitalisations (0% vs. 30%; p=0.001), and cardiac hospitalisations (13% vs. 53%; HR 0.21, 95% CI 0.07-0.63, p=0.002). While preventive ablation reduced the number of electrical storms (0% vs. 20%; p=0.01), it had no significant impact on cardiovascular mortality (13.3% vs. 26.7%; HR 0.41, 95% CI 0.12-1.38, p=0.139). Multivariate analyses were performed when events were recorded in both arms and yielded similar results.

 

Dr. Zizek said: “Our study also highlights the importance of identifying ischaemic cardiomyopathy patients with a high risk of VAs in whom substrate ablation might prevent arrhythmias and consequent debilitating ICD shocks, while outweighing the potential for procedural complications.”

 

ENDS

 

Authors: ESC Press Office
Tel: +33 (0)489 872 075

Email: press@escardio.org

Follow us on X @ESCardioNews 

 

Notes to editor

 

Funding: The study was supported by an institutional research grant from University Medical Centre Ljubljana (Grant Number: TP20180084). 

 

Disclosures: Dr. Zizek reports receiving proctoring fees and speaker honoraria from Medtronic, Biotronik, Abbott, and Boston Scientific. Two other authors also report receiving proctoring fees from Biosense Webster. The other authors report no conflict of interest.

 

References and notes

1The PREVENTIVE VT trial will be presented during the session ‘Late-Breaking Science: ablation’ which takes place on 8 April 2024 at 14:03 CEST in Room 1.

2McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726.

3Di Marco A, Anguera I, Teruel L, et al. Chronic total occlusion of an infarct-related artery: a new predictor of ventricular arrhythmias in primary prevention implantable cardioverter defibrillator patients. Europace. 2017;19(2):267-74.

 

About the European Heart Rhythm Association

The European Heart Rhythm Association (EHRA) is a branch of the European Society of Cardiology (ESC). Its aim is to improve patients’ quality of life and reduce sudden cardiac death by limiting the impact of heart rhythm disturbances. 

 

About the EHRA Congress     #EHRA2024

EHRA 2024 is the annual congress of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).

 

About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

 

Information for journalists about registration for EHRA 2024

EHRA 2024 will be held 7 to 9 April at the CityCube Berlin, Germany, and online. Explore the scientific programme.

Free registration applies to accredited press. Credentials: A valid press card or appropriate letter of assignment with proof of three recent published articles. Read the ESC media and embargo policy. The ESC Press Office will verify the documents and confirm by email that your press accreditation is valid. The ESC Press Office decision is final regarding all press registration requests. END


ELSE PRESS RELEASES FROM THIS DATE:

Cleveland Clinic’s Dr. Matt Kalaycio appointed Chair of Board of Directors for National Comprehensive Cancer Network

Cleveland Clinic’s Dr. Matt Kalaycio appointed Chair of Board of Directors for National Comprehensive Cancer Network
2024-04-08
PLYMOUTH MEETING, PA [April 8, 2024] — The National Comprehensive Cancer Network® (NCCN®)—a nonprofit devoted to patient care, research, and education—is announcing the election of Matt Kalaycio, MD, FACP, as Chair of the Board of Directors, with Christopher H. Lieu, MD, elected as Vice-Chair, succeeding Dr. Kalaycio in the position he has held since 2022. “The exemplary leadership from our board of directors is invaluable as NCCN defines and advances high-quality, high-value, patient-centered cancer care around the world,” said NCCN Chief Executive Officer Crystal S. Denlinger, ...

War in Ukraine is increasing the prevalence of mental health conditions in children, new study finds

2024-04-08
A new study presented at the European Psychiatric Association Congress 2024 reveals a significant rise in mental health issues among children and adolescents displaced by the war in Ukraine. The research, conducted by the Institute of Forensic Psychiatry of MoH of Ukraine, highlights the devastating impact of prolonged exposure to violence and displacement on the mental well-being of young people. As per UNICEF’s recent report on “The State of the World’s Children 2021”, the current COVID-pandemic ...

Using pulp and paper waste to scrub carbon from emissions

2024-04-08
Researchers at McGill University have come up with an innovative approach to improve the energy efficiency of carbon conversion, using waste material from pulp and paper production. The technique they’ve pioneered using the Canadian Light Source at the University of Saskatchewan not only reduces the energy required to convert carbon into useful products, but also reduces overall waste in the environment. “We are one of the first groups to combine biomass recycling or utilization with CO2 capture,” said Ali ...

First-in-human study demonstrates reduction of hard-to-reach ventricular tachycardias

2024-04-08
Berlin, Germany – 8 April 2024:  A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science is presented at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).1  VT is a leading cause of sudden death in patients with heart failure and a reduced ejection fraction.2 Approximately 30% of patients with ischaemic and non-ischaemic cardiomyopathies develop ventricular arrhythmias including VT.3 Typical therapies to prevent VT include antiarrhythmic medication, such as amiodarone, and an implantable ...

McMaster researchers create first-ever guidelines to help kids build tolerance to food allergens

2024-04-08
Researchers with McMaster University have crafted the first-ever guidelines to help prepare families who plan to build their child’s tolerance to common food allergens. These international guidelines, published on April 8, 2024 in the Journal of Allergy and Clinical Immunology, standardize the preparation process for families considering oral immunotherapy, a process that involves giving very small amounts of an allergen, like peanuts, to patients and gradually increasing the amount to build up their tolerance. Until now, ...

International experts agree on standards for catheter ablation of atrial fibrillation

2024-04-08
Berlin, Germany – 8 April 2024:  An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation is published today in EP Europace,1 a journal of the European Society of Cardiology (ESC), and presented at EHRA 2024, a scientific congress of the ESC.2  Lead author Dr. Stylianos Tzeis said: “Ablation is the most effective way to prevent recurrences of atrial fibrillation and delay progression to more advanced forms. Pioneering techniques have emerged since the previous consensus in 2017,3 requiring new advice on who should receive this procedure and how to perform it in the safest and most effective manner.”   Atrial ...

Virtual reality sessions lessen cancer pain in clinical trial

2024-04-08
A 10-minute virtual reality (VR) session significantly lessened pain in hospitalized patients with cancer in a recent clinical trial published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. Even a day later, participants experienced sustained benefits. Most people with cancer experience pain, and treatment usually involves medications including opioids. VR sessions that immerse the user in new environments have been shown to be a noninvasive and nonpharmacologic way to lessen pain in different patient populations, but data are lacking in individuals ...

Cannabis use during pregnancy linked to increased risk of ADHD, autism and intellectual disability in children

2024-04-08
A new study presented at the European Psychiatric Association Congress 2024 reveals a significant association between prenatal cannabis use disorder (CUD) and an increased risk of neurodevelopmental disorders in offspring, including attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and intellectual disability (ID). Cannabis remains by far the most consumed illicit drug in Europe. Around 1.3% of adults in the European Union (3.7 million people) are estimated to be ...

New study highlights the link between depression and breast cancer mortality in women

2024-04-08
A new study presented at the European Psychiatric Association Congress 2024 sheds light on the significant impact of depression on the survival rates and quality of life for women diagnosed with breast cancer. This study, conducted by a team of researchers in Russia, conducted a comprehensive analysis of existing research on the prevalence and impact of depression in breast cancer patients. Breast cancer is the most common cancer among women and a leading cause of death globally and in the EU, it is estimated that 1 in 11 women in the EU-27 will develop breast cancer ...

Key to unlocking the secret of degenerative brain disorders found

Key to unlocking the secret of degenerative brain disorders found
2024-04-08
Alzheimer's disease and Parkinson's disease, along with stroke, are among the top three neurodegenerative disorders, characterized by the malfunction and progressive degeneration of neurons, the nerve cells. Understanding the mechanisms underlying these neurological disorders and developing therapies requires labeling technologies that can visualize neuronal changes not only in normal conditions but also in disease states. A research team led by Dr. Kim Yun Kyung from the Brain Science Institute at the Korea Institute of Science and Technology (KIST), in collaboration with Professor Chang Young-Tae's team from Pohang University of Science ...

LAST 30 PRESS RELEASES:

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

Unintentional drug overdoses take a toll across the U.S. unequally, study finds

A step toward plant-based gelatin

ECMWF unveils groundbreaking ML tool for enhanced fire prediction

The food and fuel that farms itself

Patient- and Community-Level Characteristics Associated With RSV Vaccination

[Press-News.org] Preventive ablation of ventricular tachycardia avoids shocks and hospitalisation
PREVENTIVE VT trial presented in a late-breaking science session today at EHRA 2024